105 related articles for article (PubMed ID: 33418743)
1. One-Step Synthesis of Targeted Acid-Labile Polysaccharide Prodrug for Efficiently Intracellular Drug Delivery.
Li D; Feng X; Chen L; Ding J; Chen X
ACS Biomater Sci Eng; 2018 Feb; 4(2):539-546. PubMed ID: 33418743
[TBL] [Abstract][Full Text] [Related]
2. Dual-acidity-labile polysaccharide-di-drugs conjugate for targeted cancer chemotherapy.
Li D; Su T; Ma L; Yin F; Xu W; Ding J; Li Z
Eur J Med Chem; 2020 Aug; 199():112367. PubMed ID: 32474350
[TBL] [Abstract][Full Text] [Related]
3. Targeted hydroxyethyl starch prodrug for inhibiting the growth and metastasis of prostate cancer.
Zhao K; Li D; Xu W; Ding J; Jiang W; Li M; Wang C; Chen X
Biomaterials; 2017 Feb; 116():82-94. PubMed ID: 27914269
[TBL] [Abstract][Full Text] [Related]
4. Drug binding rate regulates the properties of polysaccharide prodrugs.
Li D; Ding J; Zhuang X; Chen L; Chen X
J Mater Chem B; 2016 Aug; 4(30):5167-5177. PubMed ID: 32263515
[TBL] [Abstract][Full Text] [Related]
5. Redox-Sensitive Hydroxyethyl Starch-Doxorubicin Conjugate for Tumor Targeted Drug Delivery.
Hu H; Li Y; Zhou Q; Ao Y; Yu C; Wan Y; Xu H; Li Z; Yang X
ACS Appl Mater Interfaces; 2016 Nov; 8(45):30833-30844. PubMed ID: 27791359
[TBL] [Abstract][Full Text] [Related]
6. Functional cRGD-Conjugated Polymer Prodrug for Targeted Drug Delivery to Liver Cancer Cells.
Zhou R; Zhang M; He J; Liu J; Sun X; Ni P
ACS Omega; 2022 Jun; 7(24):21325-21336. PubMed ID: 35755339
[TBL] [Abstract][Full Text] [Related]
7. Cyclo(RGD)-Decorated Reduction-Responsive Nanogels Mediate Targeted Chemotherapy of Integrin Overexpressing Human Glioblastoma In Vivo.
Chen W; Zou Y; Zhong Z; Haag R
Small; 2017 Feb; 13(6):. PubMed ID: 27865044
[TBL] [Abstract][Full Text] [Related]
8. A safe, simple and efficient doxorubicin prodrug hybrid micelle for overcoming tumor multidrug resistance and targeting delivery.
Bao Y; Yin M; Hu X; Zhuang X; Sun Y; Guo Y; Tan S; Zhang Z
J Control Release; 2016 Aug; 235():182-194. PubMed ID: 27264552
[TBL] [Abstract][Full Text] [Related]
9. A pH-responsive prodrug delivery system self-assembled from acid-labile doxorubicin-conjugated amphiphilic pH-sensitive block copolymers.
Huang X; Liao W; Xie Z; Chen D; Zhang CY
Mater Sci Eng C Mater Biol Appl; 2018 Sep; 90():27-37. PubMed ID: 29853091
[TBL] [Abstract][Full Text] [Related]
10. Tumor microenvironment-labile polymer-doxorubicin conjugate thermogel combined with docetaxel for in situ synergistic chemotherapy of hepatoma.
Zhang Y; Zhang J; Xu W; Xiao G; Ding J; Chen X
Acta Biomater; 2018 Sep; 77():63-73. PubMed ID: 30006312
[TBL] [Abstract][Full Text] [Related]
11. Targeted and Reduction-Sensitive Cross-Linked PLGA Nanotherapeutics for Safer and Enhanced Chemotherapy of Malignant Melanoma.
Wang X; Qiu M; Deng C; Cheng R; Zhong Z
ACS Biomater Sci Eng; 2020 May; 6(5):2621-2629. PubMed ID: 33463251
[TBL] [Abstract][Full Text] [Related]
12. Temperature-triggered tumor-specific delivery of anticancer agents by cRGD-conjugated thermosensitive liposomes.
Kim MS; Lee DW; Park K; Park SJ; Choi EJ; Park ES; Kim HR
Colloids Surf B Biointerfaces; 2014 Apr; 116():17-25. PubMed ID: 24441178
[TBL] [Abstract][Full Text] [Related]
13. Cyclic RGD-Functionalized and Disulfide-Crosslinked Iodine-Rich Polymersomes as a Robust and Smart Theranostic Agent for Targeted CT Imaging and Chemotherapy of Tumor.
Zou Y; Wei Y; Sun Y; Bao J; Yao F; Li Z; Meng F; Hu C; Storm G; Zhong Z
Theranostics; 2019; 9(26):8061-8072. PubMed ID: 31754381
[TBL] [Abstract][Full Text] [Related]
14. pH-Responsive prodrug nanoparticles based on a sodium alginate derivative for selective co-release of doxorubicin and curcumin into tumor cells.
Gao C; Tang F; Gong G; Zhang J; Hoi MPM; Lee SMY; Wang R
Nanoscale; 2017 Aug; 9(34):12533-12542. PubMed ID: 28819666
[TBL] [Abstract][Full Text] [Related]
15. Zwitterionic nanoparticles constructed from bioreducible RAFT-ROP double head agent for shell shedding triggered intracellular drug delivery.
Huang P; Liu J; Wang W; Zhang Y; Zhao F; Kong D; Liu J; Dong A
Acta Biomater; 2016 Aug; 40():263-272. PubMed ID: 26607767
[TBL] [Abstract][Full Text] [Related]
16. Gold Nanorods Conjugated with Doxorubicin and cRGD for Combined Anticancer Drug Delivery and PET Imaging.
Xiao Y; Hong H; Matson VZ; Javadi A; Xu W; Yang Y; Zhang Y; Engle JW; Nickles RJ; Cai W; Steeber DA; Gong S
Theranostics; 2012; 2(8):757-68. PubMed ID: 22916075
[TBL] [Abstract][Full Text] [Related]
17. α
Zhong P; Meng H; Qiu J; Zhang J; Sun H; Cheng R; Zhong Z
J Control Release; 2017 Aug; 259():176-186. PubMed ID: 27986551
[TBL] [Abstract][Full Text] [Related]
18. Stimuli-responsive PEGylated prodrugs for targeted doxorubicin delivery.
Xu M; Qian J; Liu X; Liu T; Wang H
Mater Sci Eng C Mater Biol Appl; 2015 May; 50():341-7. PubMed ID: 25746279
[TBL] [Abstract][Full Text] [Related]
19. cRGD-functionalized reduction-sensitive shell-sheddable biodegradable micelles mediate enhanced doxorubicin delivery to human glioma xenografts in vivo.
Zhu Y; Zhang J; Meng F; Deng C; Cheng R; Feijen J; Zhong Z
J Control Release; 2016 Jul; 233():29-38. PubMed ID: 27178807
[TBL] [Abstract][Full Text] [Related]
20. Dual-targeted and pH-sensitive Doxorubicin Prodrug-Microbubble Complex with Ultrasound for Tumor Treatment.
Luo W; Wen G; Yang L; Tang J; Wang J; Wang J; Zhang S; Zhang L; Ma F; Xiao L; Wang Y; Li Y
Theranostics; 2017; 7(2):452-465. PubMed ID: 28255342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
